The use of IV iron in the treatment of anaemia of ESRD patients on maintenance haemodialysis: an historical and personal view.

نویسنده

  • Stanley Shaldon
چکیده

aspects versus safety and regulations. J Am Soc Nephrol 2002; 13 [Suppl 1]: S78–S83 20. Guth HJ, Gruska S, Kraatz G. On-line production of ultrapure substitution fluid reduces TNF-alpha and IL-6 release in patients on hemodiafiltration therapy. Int J Artif Organs 2003; 26: 181–187 21. Vaslaki LR, Berta K, Major L et al. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multi-center cross-over study. Artif Organs 2005; 29: 406–412 22. Ward RA, Sadler JH. Microbiological quality requirements for dialysate: is it time for a change? Nephrol News Issues 2002; 11: 26, 28–29, 33–34, 36, 38, 40, 73

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Impact of Clinical Pharmacist-Provided Education on Medication Adherence Behaviour in ESRD Patients on Haemodialysis

      The aim of this research is to assess the impact of clinical pharmacist-provided education on medication adherence in haemodialysis patients. Ninety haemodialysis patients were randomized into two groups. Brief medication questionnaire (BMQ), a tool for screening adherence was administered to both groups at the baseline to assess adherence to antihypertensives, vitamin D analogues, phosph...

متن کامل

PHARMA COKINETICS OF RECOMBINANT ERYTHROPOIETIN AND RED CELL METABOLISM IN HAEMODIALYSIS PATIENTS

The pharmacokinetics of recombinant human erythropoietin (rHuEpo) administered intravenously has been investigated in a group of five patients with chronic renal failure who were dialysis-dependent. The half-life of circulating erythropoietin decreased from 7.9±OA hr (mean ±SO) at the beginning of treatment to 6.2±O.6 hr after 6 weeks and 5A±O.9 hr after 4 months of treatment. In spite of t...

متن کامل

بررسی اثرات تجویز آهن(خوراکی، تزریقی) و اریتروپویتین بر سطح هماتوکریت و درصد اشباع ترانسفرین در بیماران همودیالیزی

Iron deficiency anemia is one of the essential problems in hemodialysis patients and with presence of iron deficiency, EPO does not have any effect on hematocrit(HCT) level and transferrin saturation percentage(TSP). However, injection of IV iron together with EPO improves responses to anemia treatment. The aim of this study was to determine the effect of iron(oral or IV) prescription...

متن کامل

Economic appraisal of maintenance parenteral iron administration in treatment of anaemia in chronic haemodialysis patients.

BACKGROUND Iron deficiency is common in haemodialysis patients and adequate supplementation by the oral or parenteral route has been limited by drug side-effects, absorption, and cost. Intermittent doses of intravenous iron dextran complex are recommended in patients with inadequate iron stores despite maximal tolerated oral dose. We conducted a prospective study with economic analysis of a reg...

متن کامل

Prevalence of cutaneous manifestations in end stage renal disease patients under hemodialysis in Imam Khomeini Hospital, Tehran in 2003

Background and aim: New modalities in the treatment of end-stage renal disease (ESRD) patients have increased their life expectancy and quality of life. A wide range of cutaneous manifestations are seen in ESRD patients. This study was conducted to determine the prevalence of cutaneous manifestations in ESRD patients on maintenance hemodialysis in the dialysis department of Imam Khomeini ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

دوره 22 1  شماره 

صفحات  -

تاریخ انتشار 2007